Delivery Order SPE2DB22D3501-SPE2DB24FWN81
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,072.25, is for the delivery of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product. The contract is a Firm Fixed Price, Delivery Order type, with a period of performance through February 25, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $2,967.00 and a completion date of July 10, 2025. The contract is for the supply of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product, and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $3,598.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEGASYS 180 MCG/ML VIALML, with a completion date of May 20, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA0J1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEGASYS 180 MCG/ML VIALML, a medical product, with a total ceiling value of $1,381.50. It is a Firm Fixed Price delivery order contract with an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,753.32 firm fixed-price delivery order is for the supply of PEGASYS 180 MCG/ML VIALML, a specialty medication. The contract has an ultimate completion date of December 10, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,763.00, for the product PEGASYS 180 MCG/ML VIALML. The contract has an Ultimate Completion Date of June 18, 2025 and was awarded on June 17, 2025. The contract is not set aside. Amerisourcebergen Drug Corp is a for-profit...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PEGASYS 180 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a firm fixed price of $2,752.23 and a performance period ending on June 9, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order valued at $2,661.36 for the delivery of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product, with a completion date of May 21, 2024. The contract is Firm Fixed Price and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $2,763.01. The contract is not set-aside and will be performed in Conshohocken, Pennsylvania. The contract is for the supply of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product. Amerisourcebergen Drug Corp is an experienced federal...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price type and a Ceiling Value of $2,763.00. The contract is not set aside and is for the provision of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...